Tolsura™ (itraconazole) – New drug approval
December 12, 2018 - Mayne Pharma announced the FDA approval of Tolsura (itraconazole) capsules, for the treatment of the following fungal infections in immunocompromised and non-immunocompromised adult patients: blastomycosis, pulmonary and extrapulmonary; histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis; and aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy.
Top